Placeholder

The patient pipeline

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Clinical-trial recruitment and enrollment efforts are often not given high priority, causing costly delays in the development of new drugs. Unfortunately, there are no quick fixes, but companies are beginning to institute well-thought out and designed processes to bring the right patients to the right trials. Industry analysts intimate that one of the best ways to do this is for companies to take a page out of their marketing handbooks.
According to Janice Cruz Rowe, Martin E. Elling, Judith G. Hazlewood, and Randa Zakhary, authors of The McKinsey Quarterly, 2002 Number 2 report, by setting a target for the number of patients needed in a trial, the R&D team in essence creates a sales challenge: to get enough patients to buy the “product” — in this case, participation…

Sidebar:
The Web: Not a Magic Bullet
Marketing to Patients
Recruitment Standards On the Way

Experts on this topic
Scott Ballenger. VP, Sales, Acurian, Horsham, Pa.; Acurian is a leading provider of clinical-trial patient and investigator recruitment solutions for the pharmaceutical and biotech industries
Kenneth M. Borow, M.D. CEO, The Covalent Group, Wayne, Pa.; The Covalent Group provides consultative and operational services in support of the design, planning, and conduct of human clinical trials
Bonnie Brescia. President, BBK Healthcare Inc., Newton, Mass.; BBK is a leader in patient recruitment for clinical research studies
G. Stephen DeCherney, M.D., MPH. Executive VP, worldwide clinical operations, PRA International, McLean, Va.; PRA is an international drug-development organization providing services on a contract basis to the pharmaceutical and biotechnology industries
Kathleen Drennan. Chief, Global Marketing and Strategic Business Development, Iris — Global Clinical Trial Solutions, Chicago; Iris, a Corbett Healthcare Group company, is a clinically based, healthcare communications company supporting the pharmaceutical industry in Phase I-IV clinical research
Steve Engle. Chairman and CEO, La Jolla Pharmaceutical Co., San Diego; La Jolla is a biotechnology company leading the development of therapeutics for antibody-mediated autoimmune diseases afflicting several million people in the U.S. and Europe
Eric Hayashi. VP, Corporate Development, Radiant Research, Kirkland, Wash.; Radiant Research is a site management organization
Deborah Kniuksta. Assistant Director, Patient Recruitment, Kendle International Inc., Cincinnati; Kendle provides quality clinical development services for the pharmaceutical and biotechnology industries
James C. Linde. Senior Director, Clinical Services and Trial Support Services, Kendle International Inc., Cincinnati; Kendle
provides quality clinical development services for the pharmaceutical and biotechnology industries
Elizabeth Moench. President and CEO, MediciGroup Inc., King of Prussia, Pa.; MediciGroup is a communications company that specializes in patient recruitment and retention
John Yee, M.D., MPH. Senior VP, Medical Affairs, BBK Healthcare Inc., Newton, Mass.; BBK is a leader in patient recruitment for clinical research studies

FEEDBACK